{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:23:16Z","timestamp":1791328996150,"version":"4.3.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.nano.2010.07.003","type":"journal-article","created":{"date-parts":[[2010,8,7]],"date-time":"2010-08-07T04:37:38Z","timestamp":1281155858000},"page":"242-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B"],"prefix":"10.1016","volume":"7","author":[{"given":"Swarnali","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti K.","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2010.07.003_bb0005","series-title":"Ophthalmic drug delivery systems","first-page":"59","article-title":"Precorneal, corneal and postcorneal factors","author":"Lee","year":"1993"},{"key":"10.1016\/j.nano.2010.07.003_bb0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jop.1986.2.67","article-title":"Review: topical ocular drug delivery: recent developments and future challenges","volume":"2","author":"Lee","year":"1986","journal-title":"J Ocul Pharmacol"},{"key":"10.1016\/j.nano.2010.07.003_bb0015","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1016\/S0142-9612(02)00080-7","article-title":"Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application","volume":"23","author":"Pignatello","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2010.07.003_bb0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0928-0987(02)00057-X","article-title":"Eudragit RS100\u00ae nanosuspensions for the ophthalmic controlled delivery of ibuprofen","volume":"16","author":"Pignatello","year":"2002","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2010.07.003_bb0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2007.04.028","article-title":"Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability","volume":"344","author":"Morand","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2010.07.003_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)10311-8","article-title":"Mechanism of the selective toxicity of amphoterictn B incorporated into liposomes","volume":"31","author":"Juliano","year":"1987","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.nano.2010.07.003_bb0035","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0005-2736(84)90135-4","article-title":"Lipoaomal amphotericin B is toxic to fungal cells but not to mammalian cells","volume":"770","author":"Mehta","year":"1984","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nano.2010.07.003_bb0040","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","article-title":"Nanocapsule formation by interfacial polymer deposition following solvent displacement","volume":"55","author":"Fessi","year":"1989","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2010.07.003_bb0045","first-page":"69","article-title":"Antimicrobial efficacy of essential oil from Curcuma caesia","volume":"38","author":"Garg","year":"1988","journal-title":"Ind J Microbiol"},{"key":"10.1016\/j.nano.2010.07.003_bb0050","first-page":"139","article-title":"Eye irritation","volume":"Vol. 4","author":"Mc-Donald","year":"1977"},{"key":"10.1016\/j.nano.2010.07.003_bb0055","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard\u2014second edition. Document M38-A. Vol. 28, No. 16","author":"Rex","year":"2008"},{"key":"10.1016\/j.nano.2010.07.003_bb0060","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/aic.690050421","article-title":"Interfacial turbulence: hydrodynamic instability and the Marangoni effect","volume":"5","author":"Sternling","year":"1959","journal-title":"Am Inst Chem Eng J"},{"key":"10.1016\/j.nano.2010.07.003_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1179\/cmq.1982.21.2.121","article-title":"Interfacial hydrodynamics: an overview","volume":"21","author":"Berg","year":"1982","journal-title":"Can Metal Quan"},{"key":"10.1016\/j.nano.2010.07.003_bb0070","series-title":"Interface Convres. Polym. Coatings Proc","first-page":"83","article-title":"Interfacial turbulence: spontaneous emulsification and evaporative convention. Contributed discussion","author":"Wasan","year":"1967"},{"key":"10.1016\/j.nano.2010.07.003_bb0075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijpharm.2006.11.061","article-title":"Haloperidol loaded PLGA nanoparticles: systematic study of particle size and drug content","volume":"336","author":"Budhian","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2010.07.003_bb0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0168-3659(89)90059-X","article-title":"Preparation and characterization of microspheres containing the anti-inflammatory agents, indomethacin, ibuprofen, and ketoprofen","volume":"10","author":"Bodmeier","year":"1989","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2010.07.003_bb0085","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/026520499288924","article-title":"Effect of formulation variables on in vitro drug release and micrometric properties of modified release ibuprofen microspheres","volume":"16","author":"Perumal","year":"1999","journal-title":"J Microencaps"},{"key":"10.1016\/j.nano.2010.07.003_bb0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-5173(97)00194-4","article-title":"Poly (\u025b-caprolactone) nanospheres as an alternative way to reduce amphotericin B toxicity","volume":"158","author":"Espuelas","year":"1997","journal-title":"Int J Pharm"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963410002376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963410002376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:07:15Z","timestamp":1761548835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963410002376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1549963410002376"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2010.07.003","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2010.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}